METASTATIC MELANOMA
Clinical trials for METASTATIC MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug combo tested for advanced melanoma in india
Disease control Not yet recruitingThis study is testing the safety and effectiveness of a two-drug combination (nivolumab + relatlimab) for people in India with advanced melanoma that cannot be removed by surgery or has spread. The study will enroll 30 participants who have not received any prior treatment for th…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cancer clock: does morning or afternoon treatment work better?
Disease control Not yet recruitingThis study is testing whether the time of day a standard immunotherapy treatment is given affects how well it works for people with advanced solid tumors. Researchers want to see if a patient's internal body clock influences the treatment's effectiveness. About 160 participants w…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New strategy aims to tame harsh side effects of cancer immunotherapy
Disease control Not yet recruitingThis study is testing if a drug called secukinumab can help patients with advanced melanoma safely restart a powerful type of cancer treatment called immunotherapy. It focuses on patients who had to stop their previous immunotherapy due to serious side effects like severe skin ra…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC